Stay updated on Pembrolizumab and Binimetinib in TNBC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Binimetinib in TNBC Clinical Trial page.
Latest updates to the Pembrolizumab and Binimetinib in TNBC Clinical Trial page
- Check4 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3, indicating a new release.SummaryDifference0.1%
- Check11 days agoChange DetectedThe website has updated its results section by removing estimated timestamps and now displays the actual 'Results First Posted' and 'Last Update Posted' dates.SummaryDifference0.1%
- Check18 days agoChange DetectedThe latest update on the study includes the posting of results regarding the Maximum Tolerated Dose (MTD) of Pembrolizumab in combination with Binimetinib, along with detailed methodologies for assessing Objective Response Rate (ORR) and Progression Free Survival (PFS), while previous submissions and updates have been removed.SummaryDifference5%
- Check25 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.1%
- Check32 days agoNo Change Detected
- Check46 days agoChange DetectedThe website has been updated to version v2.10.0, adding 3 more conditions and indicating that the study now has 1 location, while the previous version v2.9.7 has been removed.SummaryDifference0.4%
- Check54 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab and Binimetinib in TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Binimetinib in TNBC Clinical Trial page.